Aura Biosciences (AURA): Long Focus Capital reports 4.9% ownership
Rhea-AI Filing Summary
Aura Biosciences, Inc. has a significant shareholder group reported by Long Focus Capital Management, LLC and John Helmers under a Schedule 13G. As of the close of business on June 30, 2026, they reported beneficial ownership of 5,119,582 shares of Aura Biosciences common stock, representing 4.9% of the class.
They report no sole voting or dispositive power and shared voting and dispositive power over 5,119,582 shares, held in client accounts managed by Long Focus Capital Management, LLC. The manager states that no single client owns more than 5% of the class. John Helmers controls Long Focus Capital Management, LLC.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 5,119,582 shares
Percent of class: 4.9%
Shared voting power: 5,119,582 shares
+2 more
5 metrics
Shares beneficially owned
5,119,582 shares
Beneficial ownership by Long Focus Capital Management, LLC and John Helmers as of June 30, 2026
Percent of class
4.9%
Percentage of Aura Biosciences common stock class beneficially owned as of June 30, 2026
Shared voting power
5,119,582 shares
Shares over which the reporting persons have shared power to vote
Shared dispositive power
5,119,582 shares
Shares over which the reporting persons have shared power to dispose
Ownership date
June 30, 2026
Date as of which ownership figures are reported
Key Terms
beneficially owned, shared voting power, dispositive power, percent of class, +1 more
5 terms
beneficially owned financial
"Securities reported on this statement on as being beneficially owned by Long Focus Capital Management, LLC"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
dispositive power financial
"Shared Dispositive Power 5,119,582.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
percent of class financial
"Percent of class: The information required by Item 4(b) is set forth in Row (11)"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
Investment Company Act of 1940 regulatory
"shareholders of an investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
FAQ
What stake in AURA does Long Focus Capital Management report?
Long Focus Capital Management, LLC and John Helmers report beneficial ownership of 5,119,582 Aura Biosciences shares, representing 4.9% of the common stock as of June 30, 2026, with shared voting and dispositive power over those shares.
Does any single client of Long Focus own over 5% of AURA stock?
No single client owns over 5%. The filing states that securities reported as beneficially owned by Long Focus were purchased on behalf of its clients and that no one client owns more than 5 percent of the class of such securities.
Who is the reporting person for the AURA Schedule 13G filing?
The reporting persons are Long Focus Capital Management, LLC, a Delaware single-member LLC, and John Helmers, a United States citizen who controls Long Focus, reporting beneficial ownership of Aura Biosciences common stock.
When is the AURA ownership information in this Schedule 13G effective?
The ownership information is reported as of the close of business on June 30, 2026. The certification signatures by John Helmers as Managing Member and individually are dated August 14, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.